FFIジャーナル
Online ISSN : 2436-5998
Print ISSN : 0919-9772
総説
ミオイノシトールの代謝性疾患予防作用 ー抗脂肪肝作用を中心に
島田 昌也
著者情報
解説誌・一般情報誌 認証あり

2019 年 224 巻 1 号 p. 072-078

詳細
抄録
1,2,3,4,5,6-Cyclohexanehexol inositol consists of nine distinct stereoisomers. Myo-inositol (MI) is the most prominent isomer and is widely distributed in its free form or as a bound-component of inositol phosphates (eg, phytate) or phospholipids (eg, phosphatidylinositol) in plant and animal foods. MI prevents fatty liver, even when induced by a strong lipogenic sugar such as fructose, probably due to repression of fructolysis/glycolysis and fatty acid synthesis rather than enhancement of fatty acid β-oxidation. In addition, MI promotes glucose transporter 4 translocation due to potentiation of the insulin signaling pathway in skeletal muscle following secretion of insulin. This suggests that MI is useful for the prevention of metabolic diseases such as fatty liver and diabetes.
著者関連情報
© 2019 FFIジャーナル編集委員会
前の記事 次の記事
feedback
Top